Thursday, April 16, 2015 10:22:49 PM
http://finance.yahoo.com/q/is?s=medt
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Dec 31, 2013 Sep 30, 2013
Total Revenue 36 21 - -
Cost of Revenue 29 13 - -
Gross Profit 6 7 - -
Operating Expenses
Research Development - - - -
Selling General and Administrative 67 55 23 23
Non Recurring - - - -
Others 10 10 - -
Total Operating Expenses - - - -
Operating Income or Loss (78) (50) (28) (17)
Income from Continuing Operations
Total Other Income/Expenses Net 24 (22) 12 12
Earnings Before Interest And Taxes (54) (72) (16) (5)
Interest Expense 5 6 6 6
Income Before Tax (59) (78) (22) (11)
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops (59) (78) (22) (11)
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income (52) (85) (16) (17)
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares (52) (85) (16) (17)
http://finance.yahoo.com/q/is?s=medt
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM